pharma · Muscle-invasive bladder cancer · Unresectable intrahepatic cholangiocarcinoma
Ningbo Cancer Hospital
News and analysis for Ningbo Cancer Hospital on NovaPharmaNews — regulatory, clinical, and market coverage.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 120
- Drugs
- 183
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Ningbo Cancer Hospital — regulatory, clinical, and market coverage.
News and analysis for Ningbo Cancer Hospital on NovaPharmaNews — regulatory, clinical, and market coverage.